{"time_collected":"2023-03-20 00:04:41.720416-04:00","top_headers":[{"heading":"r/ORPHSTOCK Lounge","time_posted":"2 years ago"},{"heading":"Orphazyme provides regulatory update from FDA on arimoclomol for Niemann-Pick disease type C","time_posted":"2 years ago"},{"heading":"Financial results","time_posted":"5 months ago"},{"heading":"ORPHY: Whatâ€™s next?","time_posted":"8 months ago"},{"heading":"Covert your US ORPHY stocks to something else","time_posted":"8 months ago"},{"heading":"Updated notice to holders of ADSs regarding termination of Deposit Agreement","time_posted":"9 months ago"},{"heading":"Restructuring proposal adopted by creditors","time_posted":"10 months ago"},{"heading":"$ORPH sold to $KMPH for $12.8M in cash","time_posted":"10 months ago"},{"heading":"ORPH Up or Down in future?","time_posted":"10 months ago"},{"heading":"Any good news?","time_posted":"10 months ago"}],"subreddits":{},"about":{"header":"About Community","description":"$ORPH Shareholder Discussion Forum Orphazyme A/S (ORPH), a late-stage biopharmaceutical company pioneering the heat shock protein response for the treatment of rare diseases. Any views on this forum are not to be taken as Financial Advice.","created":"Created Jun 10, 2021","stats":["1.8k Members","13 Online"]},"other_information":[]}